Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial | Zendy

Nicholas D. James | Zendy; Fiona C. Ingleby | Zendy; Noel W. Clarke | Zendy; Claire Amos | Zendy; Gerhardt Attard | Zendy; Christopher D. Brawley | Zendy; Simon Chowdhury | Zendy; William Cross | Zendy; David P. Dearnaley | Zendy; Duncan C. Gilbert | Zendy; Silke Gillessen | Zendy; Robert J. Jones | Zendy; Ruth E. Langley | Zendy; Archie Macnair | Zendy; Zafar Malik | Zendy; Malcolm D. Mason | Zendy; David Matheson | Zendy; Robin Millman | Zendy; Chris Parker | Zendy; Hannah Rush | Zendy; John M. Russell | Zendy; Carly Au | Zendy; A.W.S. Ritchie | Zendy; Ricardo Pereira Mestre | Zendy; Imtiaz Ahmed | Zendy; Alison Birtle | Zendy; Susannah Brock | Zendy; Prantik Das | Zendy; Victoria A Ford | Zendy; Emma Gray | Zendy; Robert Hughes | Zendy; Caroline Manetta | Zendy; Duncan B. McLaren | Zendy; Ashok Nikapota | Zendy; Joe M. O’Sullivan | Zendy; Carla Perna | Zendy; C. Peedell | Zendy; Andrew Protheroe | Zendy; Santhanam Sundar | Zendy; Jacob Tanguay | Zendy; Shaun Tolan | Zendy; John Wagstaff | Zendy; Jan Wallace | Zendy; James Wylie | Zendy; Anjali Zarkar | Zendy; Mahesh KB Parmar | Zendy; Matthew R. Sydes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial

Author(s) -

Nicholas D. James,

Fiona C. Ingleby,

Noel W. Clarke,

Claire Amos,

Gerhardt Attard,

Christopher D. Brawley,

Simon Chowdhury,

William Cross,

David P. Dearnaley,

Duncan C. Gilbert,

Silke Gillessen,

Robert J. Jones,

Ruth E. Langley,

Archie Macnair,

Zafar Malik,

Malcolm D. Mason,

David Matheson,

Robin Millman,

Chris Parker,

Hannah Rush,

John M. Russell,

Carly Au,

A.W.S. Ritchie,

Ricardo Pereira Mestre,

Imtiaz Ahmed,

Alison Birtle,

Susannah Brock,

Prantik Das,

Victoria A Ford,

Emma Gray,

Robert Hughes,

Caroline Manetta,

Duncan B. McLaren,

Ashok Nikapota,

Joe M. O’Sullivan,

Carla Perna,

C. Peedell,

Andrew Protheroe,

Santhanam Sundar,

Jacob Tanguay,

Shaun Tolan,

John Wagstaff,

Jan Wallace,

James Wylie,

Anjali Zarkar,

Mahesh KB Parmar,

Matthew R. Sydes

Publication year - 2022

Publication title -

jnci cancer spectrum

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.345

H-Index - 10

ISSN - 2515-5091

DOI - 10.1093/jncics/pkac043

Subject(s) - docetaxel , medicine , prostate cancer , hazard ratio , oncology , proportional hazards model , androgen deprivation therapy , confidence interval , survival analysis , progression free survival , cancer , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore